However, the recent advancements on understanding cancer cells biology and the improvements on experimental techniques andin silico approaches available for the analysis of information reported in public databases, will certainly facilitate the identification of novel B-Raf inhibitors acting through such innovative mechanisms. The gene discussed is BRAF; the disease is cancer.